2016美中抗癌协会年会召开 中美专家共探讨肿瘤新药研发

2016年6月3日至7日,一年一度的美国临床肿瘤学会年会(ASCO2016)在美国依利诺州芝加哥市召开。在ASCO会议召开首日的晚18:30-21:00点,众多中美专家齐聚第8届美中抗癌协会(USCACA)年会,交流抗癌新进展。本次年会聚焦“肿瘤新药研发”,中美专家就这一主题开展了精彩的学术报告和专题讨论。CSCO理事长、广东省人民医院吴一龙教授,中山大学肿瘤医院/肿瘤防治中心徐瑞华教授,北京大学肿瘤医院沈琳教授受邀参加此次会议。


第8届USCACA年会现场


2016苏州质子治疗培训


第二届中美质子医疗论坛


质子治疗培训班(第一期)日程表


培训时间:2016年4月22 -24日


培训地点:苏州工业园区生物纳米园学术报告厅


培训简介:


AACR will be holding the Second Shanghai Conference during November 12-15

AACR will be holding the Second Shanghai Conference entitled "New Horizons in Cancer Research" during November 12-15 in Shanghai, China. Our Board of Directors, Dr. Wei Zhang, serves on the Regional Advisory Committee and has been invited to give two presentations on cancer genomics at the conference.

The first Impact Factor of CJC is 2.155.

We are pleased to announce that the first Impact Factor of CJC is 2.155 !

Last year, the Chinese Journal of Cancer (CJC) was accepted in the Science Citation Index Expanded (SCI-E) by Thomson Reuters.

It has then been granted an Impact Factor of 2.155 for the of 2014, reflecting the citations during the year 2014 of articles published in 2012 and 2013.

Lung cancer and its prevalence in China: an Editor Q+A

Cases of lung cancer in China are rising, but why is this? Editors of a new series on lung cancer, Li Yan and Wei Zhang, explain why occurrence of lung cancer is increasing in China and the work that is being done to prevent this.

http://blogs.biomedcentral.com/on-medicine/2015/08/05/lung-cancer-preval...

Pages